Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,778 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Not nondipping but nocturnal blood pressure predicts left ventricular hypertrophy in the essential hypertensive patients: the Korean Ambulatory Blood Pressure multicenter observational study.
Yi JE, Shin J, Ihm SH, Kim JH, Park S, Kim KI, Kim WS, Pyun WB, Kim YM, Kim SK. Yi JE, et al. Among authors: kim ym, kim sk, kim ws, kim jh, kim ki. J Hypertens. 2014 Oct;32(10):1999-2004; discussion 2004. doi: 10.1097/HJH.0000000000000272. J Hypertens. 2014. PMID: 25023153
Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patients.
Jang JY, Lee SH, Kim BS, Seo HS, Kim WS, Ahn Y, Lee NH, Koh KK, Kang TS, Jo SH, Hong BK, Bae JH, Yang HM, Cha KS, Kim BS, Kwak CH, Cho DK, Kim U, Zo JH, Kang DH, Pyun WB, Chun KJ, Namgung J, Cha TJ, Juhn JH, Jung Y, Jang Y. Jang JY, et al. Among authors: kim u, kim bs, kim ws. Korean Circ J. 2015 May;45(3):225-33. doi: 10.4070/kcj.2015.45.3.225. Epub 2015 May 27. Korean Circ J. 2015. PMID: 26023311 Free PMC article.
Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients.
Jang JY, Lee SH, Kim BS, Seo HS, Kim WS, Ahn Y, Lee NH, Koh KK, Kang TS, Jo SH, Hong BK, Bae JH, Yang HM, Cha KS, Kim BS, Kwak CH, Cho DK, Kim U, Zo JH, Kang DH, Pyun WB, Chun KJ, Namgung J, Cha TJ, Juhn JH, Jung Y, Jang Y. Jang JY, et al. Among authors: kim u, kim bs, kim ws. Korean Circ J. 2015 Jul;45(4):349. doi: 10.4070/kcj.2015.45.4.349. Korean Circ J. 2015. PMID: 26240593 Free PMC article.
Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data.
Choi SI, Kim SK, Park S, Kim JH, Ihm SH, Kim GI, Kim WS, Pyun WB, Kim YM, Shin J. Choi SI, et al. Among authors: kim gi, kim ym, kim sk, kim ws, kim jh. Clin Hypertens. 2016 Jan 27;22:8. doi: 10.1186/s40885-016-0045-x. eCollection 2015. Clin Hypertens. 2016. PMID: 26893941 Free PMC article.
Erratum to: Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data.
Choi SI, Kim SK, Park S, Kim JH, Ihm SH, Kim GI, Kim WS, Pyun WB, Kim YM, Shin J. Choi SI, et al. Among authors: kim gi, kim ym, kim sk, kim ws, kim jh. Clin Hypertens. 2016 Feb 29;22:14. doi: 10.1186/s40885-016-0048-7. eCollection 2016. Clin Hypertens. 2016. PMID: 26933509 Free PMC article.
Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.
Sohn IS, Kim CJ, Ahn T, Youn HJ, Jeon HK, Ihm SH, Cho EJ, Chung WB, Chae SC, Kim WS, Nam CW, Park SM, Choi JY, Kim YK, Hong TJ, Lee HY, Cho JH, Shin ES, Yoon JH, Yang TH, Jeong MH, Lee JH, Park JI. Sohn IS, et al. Among authors: kim yk, kim cj, kim ws. Clin Ther. 2017 Aug;39(8):1628-1638. doi: 10.1016/j.clinthera.2017.06.014. Epub 2017 Jul 19. Clin Ther. 2017. PMID: 28734660 Clinical Trial.
2,778 results